Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Gynecologic oncology·2026

Same author

Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovary.

Gynecologic oncology reports·2026

Same author

Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same author

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Research square·2025

Same author

Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancers.

Clinical proteomics·2025

Same author

Race and ethnicity expression in reproductive endocrinology and infertility research studies compared with other obstetrics and gynecology subspecialty studies.

F&S reports·2024

Search research articles

Related Experiment Video

Updated: Oct 30, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Human Papilloma Virus Vaccination.

Kendal Rosalik¹, Christopher Tarney¹, Jasmine Han²

¹Madigan Army Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 9040A Jackson Ave, Joint Base Lewis-McChord, WA 98431, USA.

|July 2, 2021

Summary

Human papilloma virus (HPV) vaccination is crucial for preventing HPV-related cancers and diseases. Global challenges in vaccine distribution and acceptance hinder widespread HPV prevention efforts.

Keywords:

cervarix cervical cancer gardasil human papilloma virus vaccination

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Experiment Videos

Last Updated: Oct 30, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Area of Science:

Oncology
Virology
Public Health

Background:

Human papilloma virus (HPV) is a prevalent sexually transmitted infection linked to numerous benign and malignant conditions, accounting for up to 5% of global cancers.
Available HPV vaccines (bivalent, quadrivalent, nine-valent) are effective in preventing HPV-related diseases, yet global vaccination coverage remains suboptimal.

Purpose of the Study:

To review the challenges and advancements in human papilloma virus (HPV) vaccination.
To explore strategies for improving global vaccination coverage, addressing distribution barriers, and combating misinformation.

Main Methods:

Literature review of HPV epidemiology, vaccination efficacy, and global health challenges.
Analysis of current vaccination strategies, distribution barriers, and public acceptance factors.
Exploration of potential improvements in vaccine formulations and public health interventions.

Main Results:

HPV vaccination and screening significantly reduce HPV-related pathology.
Barriers to worldwide vaccine distribution and acceptance impede adequate vaccination coverage.
New vaccine development and improved distribution strategies are essential for global HPV control.

Conclusions:

Effective strategies are needed to encourage HPV vaccination, dispel myths, and enhance global vaccine distribution.
Continued research into improved vaccine formulations for both prevention and treatment is vital.
Combined efforts in vaccination, screening, and public education are key to reducing the global burden of HPV-related diseases.